ReviewJournal of clinical medicine2026

Clinical Outcomes with the Use of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Among Patients with Diabetes Mellitus and COVID-19: A Systematic Review of Observational Studies.

Shaden A Alkhalifah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.